Attovia Therapeutics, Inc. (ATTO)

NASDAQ: ATTO · Real-Time Price · USD

15.13

-0.68 (-4.30%)

At close: Nov 13, 2026, 4:00 PM EST

15.22

+0.08 (0.56%)

After-hours: Nov 13, 2026, 4:10 PM EST

Attovia Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	1.44	1.35	-
Revenue Growth	-	-	-
Gross Profit	-70.93	-52.8	-33.86
Operating Income	-85.62	-67.16	-41.55
Net Income	-78.87	-60.63	-39.8
Earnings Per Share	-7.49	-15.35	-11.27
EPS Growth	-	-	-

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	395.94	152.27	69.32
Total Debt	3.84	5.26	-
Net Cash (Debt)	392.1	147.01	69.32
Net Cash Growth	465.62%	112.06%	-
Net Cash Per Share	37.23	37.22	19.63

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-77.95	-59.2	-35.04
Capital Expenditures	-0.43	-2.31	-1.77
Free Cash Flow	-78.38	-61.51	-36.81
Free Cash Flow Growth	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Margin	-5945.49%	-4974.74%	-
Pretax Margin	-5477.22%	-4490.89%	-
Profit Margin	-5477.22%	-4490.89%	-
FCF Margin	-5442.78%	-4556.44%	-